TACE ± Systemic therapy

PROCEDURE2 trials

Sponsors

Zhongda Hospital

Conditions

Hepatocellular CarcinomaPortal Hypertension

Unknown Phase

CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

Zhongda HospitalHepatocellular Carcinoma, Portal Hypertension

Start: 2023-05-04End: 2023-12-31Target: 373Updated: 2023-05-31

Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)

Zhongda HospitalHepatocellular Carcinoma, Portal Hypertension

Start: 2023-05-04End: 2023-12-31Target: 228Updated: 2023-05-31